Zucara Therapeutics

Zucara Therapeutics is a diabetes life sciences company developing ZT-01, a first-in-class, once-daily therapeutic designed to prevent hypoglycemia in people with type 1 and insulin-dependent type 2 diabetes. ZT-01 works by inhibiting somatostatin, restoring glucagon secretion to prevent low blood glucose levels, improving patient health and quality of life. The company aims to revolutionize diabetes management.

Funding Round: Series B

Funding Amount: $20M

Date: 12-Nov-2024

Investors: Sanofi, Perceptive Advisors' PXV Fund I

Markets: Life Sciences, Diabetes Therapeutics, Drug Discovery, Biotechnology

HQ: Toronto, Ontario, Canada

Founded: 2015

Website: https://www.zucara.ca/

LinkedIn: https://ca.linkedin.com/company/zucara-therapeutics-inc-

Twitter: https://twitter.com/zucara_ca

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/zucara-therapeutics?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook: https://pitchbook.com/profiles/company/153094-33


Similar Startups


Leave a Comment

    🔷 Buy VC Database 🟩 Buy Startup Database 🎁 Get Free Sample

    Share this: